TTRX
Turn Therapeutics Inc. (NASDAQ)
Healthcare — Biotechnology
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Price History
Fundamentals
| Market Cap | $210.01M |
| P/E Ratio (TTM) | - |
| Forward P/E | -47.00 |
| EPS (TTM) | $-0.13 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | -129.17% |
| Debt/Equity | 98.17 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 67.3 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $26.50 |
| 52-Week Low | $2.57 |
| 50-Day Avg | $5.02 |
| 200-Day Avg | $4.25 |
| Avg Volume | 43.5K |
| Volume | 2.9K |
Performance Analysis
BULLISHTTRX shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:35 UTC
Back to Screener Export Report